The FDA’s Commissioner’s National Priority Voucher (CNPV) Pilot Program, launched in June 2025, creates a highly accelerated 1–2 month review pathway for products addressing key national health priorities such as unmet medical needs, domestic manufacturing resiliency, public health threats, healthcare affordability, and advanced therapeutic innovation. Entry into the program may occur through FDA nomination or a brief sponsor- submitted application.
White Paper
Commissioner’s National Priority Voucher (CNPV) Pilot Program
Related Resources
All Resources
post
FDA PreCheck Pilot: A Smarter, Infrastructure-Centered Alternative to Fast Track and Breakthrough Designations
Read More
post
Why Strong Technical + Regulatory Alignment Matters
Read More
post
Building a QMS (Quality Management System) for Medical Device
Read More
white-paper
Assessing Animal-Derived Raw Materials for Viral Risk
Read More
Let's move from science to success.
Let’s Talk